Follow-up Results of HCV GT2 Patients After Sofosbuvir/Ribavirin Therapy: Careful Attention to Occurrence of HCC.
Kaneko T, Kanda T, Nirei K, Matsumoto N, Yamazaki M, Shibata T, Tamura A, Ogawa M, Nakajima N, Matsuoka S, Kuroda K, Komoriya T, Yamamoto T, Takayama T, Moriyama M.
Kaneko T, et al. Among authors: kuroda k.
Anticancer Res. 2019 Jul;39(7):3855-3862. doi: 10.21873/anticanres.13535.
Anticancer Res. 2019.
PMID: 31262913